Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
12.26
+0.20 (1.66%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $167 million as of June 9, 2026. Its market cap has increased by 89.94% in one year.
Market Cap
167.00M
Enterprise Value
-19.48M
1-Year Change
89.94%
Ranking
Category
Stock Price
$12.26
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $167.00M, a decrease of -31.45%. That is a compound annual growth rate of -5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 167.00M | 160.14% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 184.76M |
| MediWound | 182.24M |
| Alector | 181.53M |
| Nkarta | 179.58M |
| Tonix Pharmaceuticals Holding | 176.46M |
| Cartesian Therapeutics | 171.59M |
| Enlivex | 171.14M |
| OnKure Therapeutics | 169.26M |